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OBJECTIVES This study was undertaken to evaluate the long-term results of balloon angioplasty (BA) for
postsurgical recoarctation in infants.
BACKGROUND Balloon angioplasty is a well-accepted modality for the treatment of recoarctation.
However, infants remain a group of concern because of their size, risk for complications
and the potential for restenosis with growth. Age ,12 months has been determined to
be a risk factor for the development of recoarctation after angioplasty for native
coarctation. Although studies on postsurgical coarctation have found no relationship
between age at angioplasty and the development of recoarctation, few studies specifically
addressing infants have been performed.
METHODS Clinical, echocardiographic, hemodynamic and angiographic data on 22 consecutive children
,1 year of age who underwent BA between 1986 and 1996 were reviewed.
RESULTS A successful result, defined as a postprocedure gradient of #20 mm Hg, was achieved in 20
of 22 (91%) infants with a reduction in the systolic peak pressure gradient from 48 6 27 to
9 6 10 mm Hg (p , 0.001) and an increase in coarctation diameter from 2.7 6 1.1 to 5.2 6
1.5 mm (p , 0.001). At long-term follow-up of a median of 56 months (0.6 to 12 years), the
restenosis rate after an initial optimal result was 16% (3 of 19). Five (24%) infants required
reintervention (2 initially unsuccessful; 3 recoarctation), with a success rate of 95% after two
procedures. Suboptimal long-term outcome correlated with a lower infant weight.
CONCLUSIONS Balloon angioplasty can be safely performed in infants, with good long-term results. The risk
of restenosis is low and can be successfully managed with repeat angioplasty. (J Am Coll
Cardiol 2000;35:209–13) © 1999 by the American College of Cardiology
The immediate results with balloon angioplasty (BA) for
coarctation (CoA) of the aorta are gratifying. However,
concerns remain about its use in children, especially in
infants, who are at a higher risk for complications because of
their size, smaller vessels and the potential for restenosis
with growth.
The acute results of BA for native and postoperative
recurrent CoA in infants appear to be similar (1). However,
the long-term recoarctation rate in native CoA in infants
remains high (2). The mechanism of recoarctation, al-
though undetermined, is presumably different in native and
postsurgical CoA, as the substrate is different. Potentially,
growth in childhood with a growth lag of the coarcted
segment could play a role in restenosis. This hypothesis
would make age a factor in determining the long-term
results of BA in both native and postsurgical CoA of the
aorta in infants. Age less than 12 months has been deter-
mined to be a risk factor for the development of recoarcta-
tion after angioplasty for native coarctation (2,3).
However, studies on postsurgical CoA have found no
relation between age at angioplasty and the development
of recoarctation (4), although a specific study focusing on
infants to determine their outcome has not been per-
formed, to our knowledge. As a sizable number of infants
have undergone BA for postsurgical CoA at our institu-
tion and follow-up for up to 12 years is now available, we
performed this retrospective study to analyze the long-
term impact of BA in this subgroup of children and to
determine the incidence of recoarctation in infants with
growth.
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METHODS
Twenty-two consecutive infants underwent BA at our
institution for recurrent CoA of the aorta after surgical
repair between May 1986 and July 1996. Eighteen of these
infants had been operated on at our hospital. During that
period, the total number of infants undergoing CoA repair
at our institution was 80 (recoarctation: 22%). In the
catheterization laboratory, a peak-to-peak gradient
$20 mm Hg in the presence of angiographic evidence of
CoA was used as the criteria to attempt BA.
Angioplasty. All cases were done under conscious sedation
using local anesthesia. The technique for BA of a CoA has
been well described (5,6). In brief, after administering
heparin (100 IU/kg), a diagnostic right and left heart
hemodynamic catheterization is performed. The CoA site is
crossed in a retrograde fashion, and peak and mean pressure
gradients are recorded on pullback or by simultaneous
ascending and descending aortic pressure measurements.
Biplane angiography is performed, and the diameters of the
aorta at the level of the isthmus, CoA segment and
descending aorta (DAo) distal to the CoA and at the level
of the diaphragm are measured. A balloon of a size equal to
or slightly less than the diameter of the DAo at the level of
the diaphragm is selected. The balloon catheter is passed
over an exchange guide wire and inflated until the “waist”
disappears using a low-pressure balloon initially, and a
higher-pressure balloon if necessary. An angiographic cath-
eter is then advanced to the ascending aorta (AAo) over the
guidewire, and hemodynamic and angiographic studies are
repeated. Angioplasty is repeated with a larger balloon (not
larger than the diameter of the aorta at the level of the
diaphragm) if the residual gradient is .20 mm Hg and
there is angiographic evidence of persistent narrowing
without any evidence of significant intimal tears.
Follow-up. The details of the clinical history and cardiac
catheterization were retrospectively reviewed. Follow-up
data were obtained by review of the cardiology charts, the
most recent echocardiogram and/or MRI (magnetic reso-
nance imaging) and, when available, results of repeat cardiac
catheterization. Restenosis was clinically determined either
by measurement of arm-to-leg gradients by sphygmoma-
nometry using the leg through which vascular access was not
obtained and/or by echocardiographic evaluation in cases
where arm-to-leg gradients were not reliable (one patient,
anomalous origin of the right subclavian artery below the
level of the CoA and subclavian flap procedure). Standard
echocardiographic findings were used for the diagnosis of
CoA including two-dimensional imaging of an anatomic
narrowing and/or Doppler evidence of a high-velocity jet
with antegrade flow extending into diastole.
Statistical analysis. Results are expressed as a mean 6 SD
or as a median with a range. Comparison between values
before and after BA was made by two-tailed paired t tests.
A p value #0.05 was considered significant. Factors asso-
ciated with a need for, and time to, reintervention were
initially sought using a univariable Cox proportional hazards
model. The variables significant in the univariable analysis
were then tested in a multivariable analysis. This analysis
was performed using SAS statistical software.
RESULTS
Patient demographics. Twenty-two infants (13 male, 9
female) ,1 year of age underwent BA for recurrent CoA at
a median age of 5.8 months (range: 1.5 to 11.7 months) and
median weight of 6.1 kg (range: 2.4 to 8.4 kg). The median
age at surgery was 6.5 days (range: 1 to 38 days), and the
mean time from surgical repair to angioplasty was 5.9 6 3.4
months. The surgical procedures included end-to-end anas-
tomosis (n 5 6), extended end-to-end (n 5 7), subclavian
flap (n 5 7) and a Norwood repair (n 5 2). Although eight
(36%) infants had an isolated CoA, others had associated
defects, including a bicuspid aortic valve (n 5 1), ventricular
septal defect (n 5 5), both a bicuspid aortic valve and a
ventricular septal defect (n 5 3), Shone’s complex (n 5 3),
double inlet left ventricle (n 5 1), Scimitar syndrome (n 5
1) and hypoplastic left heart syndrome after stage 1 Nor-
wood repair (n 5 2).
The reason for referral for possible angioplasty was the
presence of recoarctation as determined clinically by the
referring cardiologist based on an arm-leg gradient
$20 mm Hg determined by sphygmomanometry or on
echocardiographic findings as detailed in the preceding
section. Nineteen of the 22 patients were felt to have
recurrent obstruction, while three of the infants had docu-
mented residual gradients $20 mm Hg in the immediate
surgical postoperative period.
Immediate results. The hemodynamic and angiographic
results before and after angioplasty are summarized in Table
1.
We considered a residual peak systolic gradient of
#20 mm Hg at the end of the procedure a successful result.
Of the 22 patients who underwent angioplasty, the proce-
dure was successful in 20. Although two patients were
considered to have an unsuccessful result based on the
criteria used to define success of a gradient #20 mm Hg, the
gradient had decreased from 93 to 30 mm Hg in one infant
and from 120 to 35 in the other infant. Balloon angioplasty
was not repeated with a larger balloon in these two patients,
because the initial balloon size was equal to the diameter of
Abbreviations and Acronyms
AAo 5 ascending aorta
BA 5 balloon angioplasty
CoA 5 coarctation
DAo 5 descending aorta
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the DAo at the level of the diaphragm and because of the
presence, angiographically, of intimal tears.
Follow-up. Criteria for a successful result on follow-up
were a blood pressure gradient #20 mm Hg; absence of
echocardiographic evidence of recoarctation, and/or a peak-
to-peak systolic pressure gradient #20 mm Hg on repeat
cardiac catheterization.
The median length of follow-up was 56 months, with a
mean of 55 months (range: 0.6 to 12 years). Four patients
were followed at other institutions, and clinical follow-up
was obtained by contacting the primary cardiologist. Of
these four patients, one was lost to follow-up; therefore,
follow-up data were obtained on 21 patients.
Reintervention. We defined reintervention as a procedure
performed for either recurrent CoA after an optimal initial
angioplasty, or for a persistent residual gradient after the
first procedure. As in the first angioplasty, we considered a
residual peak systolic gradient of #20 mm Hg at the end of
the procedure a successful result. Five patients required
reintervention, including the two infants with the initial
unsuccessful result who on subsequent angioplasty had the
obstruction successfully relieved. The other three infants
developed recoarctation after initially satisfactory procedures
and underwent repeat angioplasty 6, 9 and 20 months after
the initial procedure. Two of these were successful, but one
was unsuccessful with a persistent gradient of 25 mm Hg.
This patient subsequently underwent an unsuccessful at-
tempt at surgical relief of the CoA, followed by a third
unsuccessful angioplasty, and died two years later of sepsis.
Interestingly, all the reinterventions were performed in
the first two years after the initial BA. This is demonstrated
in the Kaplan-Meier curve (Fig. 1).
The following variables possibly associated with the need
for reintervention were initially analyzed using a univariable
analysis: type of coarctation repair (p 5 0.6); age of the
infants (p 5 0.1); weight of the infants (p 5 0.05); pre-peak
systolic gradient (p 5 0.05); CoA diameter pre- (p 5 0.5)
and post-BA (p 5 0.2); AAo (p 5 0.7), transverse arch (p 5
0.4) and isthmus (p 5 0.1) dimensions (as is and after
calculating a ratio based on body weight); mean CoA:DAo
ratio (p 5 0.3); balloon:CoA ratio (p 5 0.2); balloon
diameter (p 5 0.08); balloon:DAo ratio (p 5 0.9); and
balloon:isthmus ratio (p 5 0.3). By univariable analysis, a
lower weight and a higher pre-peak systolic gradient were
associated with an increased likelihood of reintervention.
However, in the multivariable model, only weight remained
significantly associated with an increased risk of reinterven-
tion (risk ratio: 0.5, CI: 0.3 to 1).
Mortality. During the period of follow-up, two patients
died of unrelated causes 9 and 48 months after the proce-
dure. One had Shone’s complex and died in the operating
room during an attempt at a mitral valve replacement; the
other was asplenic and succumbed to overwhelming sepsis.
There was no mortality related to the procedure, and the
two late deaths in the group were unrelated procedurally or
otherwise to the CoA.
Follow-up after reintervention. On follow-up of the sur-
viving 19 patients, there was no evidence of recoarctation
(gradient #20 mm Hg) by blood pressure measurements or
echocardiography. Nine patients underwent repeat cardiac
catheterization for unrelated causes (mitral stenosis, 1;
subaortic membrane, 2; pulmonary hemorrhage, 1, Ka-
wasaki disease, 1; pre-Fontan, 2; pre-Glenn, 1; SVC ob-
struction, 1) and had no evidence of recoarctation (residual
Figure 1. Kaplan-Meier curve demonstrating proportion free from
reintervention after initial balloon angioplasty (BA) (n at initial
BA 5 22). Note that all the reinterventions were performed in the
first two years after the initial BA.
Table 1. Hemodynamic and Angiographic Parameters Before and After BA
(No Missing Values)
Pre-BA Post-BA % Change p Value
Systolic peak pressure
gradient (mm Hg)
48 6 27 9 6 10 280 6 21 , 0.001
AAo peak systolic pressure
(mm Hg)
127 6 25 107 6 17 216 6 28 , 0.005
DAo peak systolic pressure
(mm Hg)
79 6 16 98 6 19 124 6 19 , 0.001
Mean CoA diameter (mm) 2.7 6 1.1 5.2 6 1.5 193 6 86 , 0.001
Mean CoA: DAo ratio 0.4 6 0.1 0.7 6 0.2 175 6 72 , 0.001
211JACC Vol. 35, No. 1, 2000 Maheshwari et al.
January 2000:209–13 Angioplasty for Recoarctation in Infants
gradient #20 mm Hg), although two patients with no
gradient at rest had a 25 to 30 mm Hg gradient after
administration of isoproterenol. A controversial decision to
place a stent for mild angiographic narrowing was made in
one patient to improve his post-Fontan hemodynamics.
This was not considered “reintervention” for recoarctation
as the gradient in the catheterization laboratory was
#20 mm Hg.
Persistent systemic hypertension requiring treatment
with antihypertensive medications was not detected in any
of the 19 patients on follow-up. Aneurysms were not
detected in any of the 15 patients who were evaluated by
MRI and/or follow-up angiography. Femoral artery occlu-
sion was noted in one patient, secondary to a cutdown
procedure at the time of the initial catheterization, which
was performed in the earlier part of this series.
DISCUSSION
The merits, especially in the short term, of angioplasty are
clear. Long-term results can now be critically analyzed, as
more than 15 years have passed since the initial series of BA
for recurrent CoA (7). Our study sought to ascertain
whether the initial success in the cardiac catheterization
laboratory was sustained and to determine the incidence of
restenosis in infants as compared with older children and
with infants with native CoA.
Initial success. In our series, the initial success rate was
91% (20 of 22 patients), which compares favorably with the
72% to 90% (4,6,8–10) reported in other series of recurrent
CoA and which included children from all age groups, and
also with the high success rate in native CoA. Data from
Valvuloplasty and Angioplasty of Congenital Anomalies
(VACA) registry (11) suggest that better results seem to
occur when angioplasty is performed at an earlier rather
than a later age after residual obstruction is found. Thus,
infants may have a better result from BA than older children
with surgical recoarctation, possibly because of less scar
tissue and fibrosis. This may explain our high initial success
rate of 91%.
Reintervention. In our series of infants with recoarctation,
76% (16 of 21 infants) required only one BA. After two
procedures the success rate was 95% (20 of 21 patients). The
reported incidence of restenosis in follow-up studies of BA
performed on children of all ages varies from 0% to 28%
(4,8–10). A recent 12-year review of BA for recoarctation in
children by Yetman et al. (4), published in this Journal,
which is the longest follow-up study to date, reports a
reintervention rate of 28% and a restenosis rate of 25% (19
of 74 patients). In our study, which also has a follow-up of
up to 12 years, and which included only infants, the
reintervention rate was 24% (5 of 21 patients), whereas the
restenosis rate was 16% (3 of the 19 patients with an initial
optimal result).
Another long-term study (10), which included 16 infants,
had no evidence of restenosis at a median follow-up of five
years. The lower incidence of restenosis in infants may
suggest that infant aortas are capable of remodeling at the
site of the CoA and growing with time, despite relatively
small pre- and postnatal dimensions.
Our data suggested that infants with lower weights had a
higher incidence of reintervention. Additionally, although
the difference between the ages of the group that required
one versus two interventions did not attain statistical sig-
nificance, in part due to our small numbers, the trend
suggested that younger infants had a higher incidence of
residual gradients and restenosis with growth.
Complications. In addition to the encouraging finding of a
low risk of restenosis in our study, the incidence of signif-
icant long-term complications was also low. No acute
aneurysms were noted, and later development of aneurysms
was not found in the 15 patients who were evaluated by
either repeat angiography or MRI. No patients had hyper-
tension requiring therapy, although 24-h blood pressure
monitoring was not employed in the evaluation. In addition,
no unusual long-term complications have been noted.
The surgical literature reports a restenosis rate varying
from 7% to 30% in children after surgical correction of
recoarctation (12,13). Although the incidence of recurrent
recoarctation is similar with BA, the advantages of angio-
plasty vis-a`-vis surgery in infants are well-known and
include the avoidance of general anesthesia, a second tho-
racotomy and a shorter hospital stay.
Both the morbidity and the mortality associated with the
angioplasty procedure itself have been reduced considerably
since earlier reports. The VACA registry reported a 2.5%
mortality in 1990 (11). Mortality rates after surgery for
recoarctation have also decreased from a reported incidence
of 33% in 1965 (14) to 5% to 7% in recent series (12,15).
Although mortality after surgery has decreased, the risk is
still significant. Additionally, the operative morbidity re-
mains relatively high (12). Acute complications and mor-
bidity after BA are low (4), especially with the advent of
low-profile balloons that require smaller sheaths and with
refinements in the angioplasty technique. In our series, there
were no mortalities related to the procedure, thus making
angioplasty, a safe alternative to surgery for infants.
Native coarctation. By contrast to our findings in recur-
rent CoA in infants, the reported results in native CoA
remain less satisfying. Rao et al. (2), in a five- to nine-year
follow-up series, reported a 50% incidence of restenosis in
infants (5 of 6 neonates and 7 of 18 infants 1 to 12 months
of age). This would suggest that factors other than age are
responsible for the disparity in results between native and
recurrent CoA angioplasty; the presence of ductal tissue in
native CoA could potentially be a factor contributing to
restenosis in those infants.
Conclusions. This study confirms the finding of other
studies that BA is safe and effective in the treatment of
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recurrent CoA. In children ,1 year of age, it has good
long-term results. The risk of restenosis with growth in
childhood is low and can be successfully managed with
repeat angioplasty. Smaller size of the infants correlated
with a suboptimal long-term outcome.
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